AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,140,843 | -69.9% | 59,248 | -69.1% | 0.01% | -70.4% |
| Q2 2023 | $13,761,980 | +3033.3% | 191,511 | +2589.4% | 0.03% | +2600.0% |
| Q1 2023 | $439,223 | -58.1% | 7,121 | -74.0% | 0.00% | -50.0% |
| Q2 2022 | $1,049,000 | -20.7% | 27,393 | +17.2% | 0.00% | -66.7% |
| Q1 2021 | $1,323,000 | -71.7% | 23,374 | -70.6% | 0.01% | -87.2% |
| Q1 2020 | $4,674,000 | – | 79,454 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |